A Phase IV, Prospective, Non-Interventional, Multicenter Study Evaluating the Efficacy and Safety of Tolvaptan in Patients with Heart Failure
Phase of Trial: Phase IV
Latest Information Update: 31 Mar 2018
At a glance
- Drugs Tolvaptan (Primary)
- Indications Heart failure
- Focus Adverse reactions; Therapeutic Use
- Acronyms SMILE
- 31 Mar 2018 According to results published in the Circulation Journal, the study period was from 2011 to 2016.
- 31 Mar 2018 Status changed from active, no longer recruiting to completed, according to results published in the Circulation Journal.
- 31 Mar 2018 Results (n=3349) assessing the risk score to predict the prevalence of hypernatremia using the final dataset of this study, published in the Circulation Journal.